Parabolic Drugs Financials
NSE: PARABDRUGS | BSE: 533211
₹5.50
As on 25-Jan-2021IST
Market cap
₹35 Cr
Revenue (TTM)
₹0 Cr
P/E Ratio
--
P/B Ratio
-0
Div. Yield
0 %
Income Statement (₹ Cr) |
TTM | Mar-18 | Mar-17 | Mar-16 | Mar-15 | Mar-14 | Mar-13 | Mar-12 | Mar-11 | Mar-10 | Mar-09 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
--
|
72.60
|
73.72
|
75.60
|
231.78
|
437.92
|
|||||
|
Total Income
|
0.27
|
76.71
|
77.98
|
75.90
|
233.02
|
450.58
|
|||||
|
Total Expenditure
|
3.87
|
101.11
|
151.07
|
426.49
|
359.51
|
568.65
|
|||||
|
EBITDA
|
-3.87
|
-28.51
|
-77.35
|
-350.90
|
-127.73
|
-130.73
|
|||||
|
Depreciation
|
15.58
|
21.59
|
21.85
|
22.55
|
23.82
|
18.88
|
|||||
|
EBIT
|
-19.45
|
-50.10
|
-99.20
|
-373.45
|
-151.55
|
-149.61
|
|||||
|
Interest
|
0.80
|
9.25
|
10.07
|
107.62
|
98.69
|
83.07
|
|||||
|
Other Income
|
0.27
|
4.11
|
4.25
|
0.31
|
1.24
|
12.66
|
|||||
|
Exceptional Items
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Profit before Tax
|
-19.98
|
-55.24
|
-105.02
|
-480.76
|
-249.00
|
-220.02
|
|||||
|
Provision for Tax
|
--
|
1.76
|
3.05
|
4.43
|
130.33
|
-88.28
|
|||||
|
Profit after Tax
|
-19.98
|
-57.00
|
-108.07
|
-485.19
|
-379.32
|
-131.73
|
Liabilities (₹ Cr) |
TTM | Mar-18 | Mar-17 | Mar-16 | Mar-15 | Mar-14 | Mar-13 | Mar-12 | Mar-11 | Mar-10 | Mar-09 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
-927.71
|
-846.33
|
-789.33
|
-681.26
|
-196.07
|
182.92
|
|||||
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Non-Current Liabilities
|
866.65
|
872.07
|
870.46
|
762.93
|
591.21
|
432.50
|
|||||
|
Current Liabilities
|
400.41
|
393.20
|
412.24
|
495.33
|
555.00
|
506.90
|
|||||
|
Total Liabilities
|
339.35
|
418.94
|
493.37
|
577.00
|
950.14
|
1,227.19
|
Assets (₹ Cr) |
TTM | Mar-18 | Mar-17 | Mar-16 | Mar-15 | Mar-14 | Mar-13 | Mar-12 | Mar-11 | Mar-10 | Mar-09 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
280.17
|
339.23
|
361.68
|
384.03
|
407.97
|
418.38
|
|||||
|
Current Assets
|
59.19
|
77.53
|
116.56
|
146.20
|
450.89
|
566.33
|
|||||
|
Total Assets
|
339.36
|
418.94
|
493.37
|
577.00
|
950.14
|
1,227.19
|
|||||
|
Total Debt*
|
--
|
984.11
|
979.46
|
971.74
|
957.49
|
841.93
|
|||||
|
Net Current Assets
|
-341.22
|
-315.67
|
-295.68
|
-349.13
|
-104.11
|
59.42
|
|||||
|
Contingent Liabilities
|
--
|
6.25
|
6.25
|
--
|
8.33
|
91.83
|
Cashflow (₹ Cr) |
TTM | Mar-18 | Mar-17 | Mar-16 | Mar-15 | Mar-14 | Mar-13 | Mar-12 | Mar-11 | Mar-10 | Mar-09 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
3.02
|
1.65
|
89.58
|
-3.94
|
27.94
|
|||||
|
Cash Flow from Investing Activities
|
--
|
0.86
|
0.50
|
1.39
|
-15.89
|
-29.99
|
|||||
|
Cash from Financing Activities
|
--
|
-3.70
|
-2.19
|
-93.36
|
16.87
|
-4.06
|
|||||
|
Net Cash Inflow / Outflow
|
--
|
0.18
|
-0.03
|
-2.39
|
-2.96
|
-6.11
|
Financials Ratios |
TTM | Mar-18 | Mar-17 | Mar-16 | Mar-15 | Mar-14 | Mar-13 | Mar-12 | Mar-11 | Mar-10 | Mar-09 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS (₹)
|
-3.23
|
-9.21
|
-17.46
|
-78.39
|
-61.29
|
-21.28
|
|||||
|
Cash EPS (₹)
|
--
|
-5.72
|
-13.93
|
-74.75
|
-57.44
|
-18.23
|
|||||
|
Adjusted Book Value (₹)
|
--
|
-141.30
|
-134.18
|
-121.83
|
-50.63
|
3.12
|
|||||
|
Dividend per Share (₹)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Cash Flow per Share (₹)
|
--
|
0.49
|
0.27
|
14.47
|
-0.64
|
4.51
|
|||||
|
Free Cash Flow per Share (₹)
|
--
|
-3.24
|
-6.94
|
-10.82
|
-47.66
|
-11.04
|
Profitability Ratios |
TTM | Mar-18 | Mar-17 | Mar-16 | Mar-15 | Mar-14 | Mar-13 | Mar-12 | Mar-11 | Mar-10 | Mar-09 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
-29.62
|
-45.35
|
-81.66
|
-19.30
|
-15.36
|
|||||
|
ROE (%)
|
--
|
--
|
--
|
--
|
--
|
-209.38
|
|||||
|
ROA (%)
|
-11.78
|
-12.50
|
-20.19
|
-63.54
|
-36.61
|
-11.37
|
|||||
|
EBIT Margin (%)
|
--
|
-69.01
|
-134.56
|
-494.00
|
-65.39
|
-34.16
|
|||||
|
Net Margin (%)
|
-7,345.96
|
-74.31
|
-138.59
|
-639.24
|
-162.79
|
-29.24
|
|||||
|
Cash Profit Margin (%)
|
--
|
-48.78
|
-116.95
|
-547.67
|
-146.34
|
-24.84
|
Growth Ratios |
TTM | Mar-18 | Mar-17 | Mar-16 | Mar-15 | Mar-14 | Mar-13 | Mar-12 | Mar-11 | Mar-10 | Mar-09 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
--
|
-1.52
|
-2.48
|
-67.38
|
-47.07
|
-42.81
|
|||||
|
EBIT Growth (%)
|
13.75
|
49.50
|
73.44
|
-146.42
|
-1.30
|
-16.56
|
|||||
|
Net Profit Growth (%)
|
10.43
|
47.25
|
77.73
|
-27.91
|
-187.95
|
5.74
|
|||||
|
EPS Growth (%)
|
17.51
|
47.25
|
77.73
|
-27.91
|
-187.95
|
5.74
|
|||||
|
Book Value Growth (%)
|
--
|
-5.30
|
-10.14
|
-140.64
|
-1,723.47
|
-81.88
|
Valuation Ratios |
TTM | Mar-18 | Mar-17 | Mar-16 | Mar-15 | Mar-14 | Mar-13 | Mar-12 | Mar-11 | Mar-10 | Mar-09 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Price / Book Value
|
-0.04
|
-0.05
|
-0.06
|
-0.04
|
-0.18
|
1.43
|
|||||
|
Dividend Yield (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
EV/EBITDA
|
-283.18
|
-42.17
|
-14.13
|
-2.87
|
-7.99
|
-7.31
|
|||||
|
Close Price (₹)
|
5.05
|
7.40
|
8.50
|
5.40
|
8.75
|
4.40
|
|||||
|
High Price (₹)
|
5.21
|
12.00
|
10.40
|
15.75
|
18.20
|
8.49
|
|||||
|
Low Price (₹)
|
0.65
|
5.50
|
3.45
|
5.00
|
4.60
|
3.39
|
|||||
|
Market Cap (₹ Cr)
|
35.28
|
46.11
|
53.72
|
33.42
|
56.69
|
27.54
|
Solvency Ratios |
TTM | Mar-18 | Mar-17 | Mar-16 | Mar-15 | Mar-14 | Mar-13 | Mar-12 | Mar-11 | Mar-10 | Mar-09 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
--
|
-1.13
|
-1.18
|
-1.29
|
-3.06
|
43.62
|
|||||
|
Short term debt to equity ratio
|
--
|
-0.17
|
-0.18
|
-0.35
|
-2.01
|
1.68
|
|||||
|
Current Ratio
|
0.15
|
0.20
|
0.28
|
0.30
|
0.81
|
1.12
|
|||||
|
Quick Ratio
|
0.15
|
0.16
|
0.25
|
0.21
|
0.24
|
0.39
|
|||||
|
Interest Coverage
|
-23.88
|
-4.97
|
-9.43
|
-3.47
|
-1.52
|
-1.65
|
Operating Efficiency Ratios |
TTM | Mar-18 | Mar-17 | Mar-16 | Mar-15 | Mar-14 | Mar-13 | Mar-12 | Mar-11 | Mar-10 | Mar-09 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
--
|
39.70
|
90.83
|
92.68
|
42.30
|
34.02
|
|||||
|
Asset Turnover
|
--
|
0.16
|
0.14
|
0.11
|
0.23
|
0.39
|
|||||
|
Receivable days
|
--
|
240.79
|
339.20
|
363.19
|
185.58
|
115.53
|
|||||
|
Inventory Days
|
--
|
78.26
|
137.02
|
768.01
|
513.07
|
288.74
|
|||||
|
Payable days
|
--
|
537.04
|
395.15
|
108.54
|
207.89
|
155.29
|
|||||
|
Cash Conversion Cycle
|
--
|
-217.99
|
81.07
|
1,022.66
|
490.75
|
248.98
|